Zefei Jiang

11PUBLICATIONS
84CO-AUTHORS
Artificial life and complex adaptive systemsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 13, 2026
Artificial intelligence in breast cancer: applications and advancements.

Jianbin Li, Zefei Jiang

|Mar 21, 2026
Dalpiciclib plus chidamide in HR + /HER2-advanced breast cancer after CDK4/6 inhibitor failure: a phase Ib trial.

Jinmei Zhou, Xuexue Wu, Yimeng Du

|Mar 18, 2025
Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Wolfgang Janni, Thomas W P Friedl, Tracy C Yab

|May 16, 2024
Primary results of ELAINA: a randomized, multicenter, open-label, phase III study of the efficacy and safety of trastuzumab emtansine vs. lapatinib plus capecitabine in Chinese patients with HER2-positive locally advanced or metastatic breast cancer who have received prior trastuzumab-based therapy.

Xiaojia Wang, Wei Li, Yongmei Yin

|Jan 08, 2024
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial.

Zefei Jiang, Quchang Ouyang, Tao Sun

|Dec 07, 2023
Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China.

Shaohua Zhang, Jianbin Li, Ruonan Xu

Pageof 2

Frequent Collaborators

2 joint publications

Shaohua Zhang

2 joint publications

Jianyun Nie

2 joint publications

Yiding Chen

2 joint publications

Ying Lin